Cellular Agriculture Patents

Cellular agriculture patents cover myosatellite cell isolation and expansion; scaffold design for muscle tissue formation; serum-free growth factor media; bioreactor design for adherent or suspension cell culture; and post-processing for final meat-like texture — with IP concentrated in a set of well-funded cultivated meat startups and academic institutions: MAJOR CELLULAR AGRICULTURE PATENT HOLDERS: UPSIDE FOODS (FORMERLY MEMPHIS MEATS): 100+; specific cultivated meat (specific specific myosatellite cell isolation: specific specific biopsy needle for specific specific skeletal muscle biopsy from specific specific bovine animal at specific specific <1cm3 tissue for specific specific satellite cell isolation via specific specific enzyme collagenase+dispase digestion at specific specific 37°C 60min followed by specific specific differential centrifugation+magnetic bead CD56 positive selection for specific specific bovine satellite cell BSC isolation; specific specific scaffold-free thick tissue: specific specific high-density BSC seeding onto specific specific fibrin hydrogel or specific specific gelatin methacryloyl GelMA scaffold for specific specific 3D muscle bundle formation > specific specific 3mm thickness without specific specific vascular channel for specific specific whole-cut meat analog vs. specific specific ground meat format); GOOD MEAT (EAT JUST): 100+; specific cultivated chicken (specific specific large-scale suspension bioreactor: specific specific 250,000L stainless steel bioreactor for specific specific microcarrier-adapted myoblast cells at specific specific 5-50μm dextran microcarrier for specific specific adherent cell suspension culture for specific specific world-first regulatory approval Singapore SFA 2020 + specific specific FDA approval USDA-FSIS joint 2023; specific specific serum-free suspension: specific specific cell line adapted to specific specific suspension growth without specific specific microcarrier at specific specific 1-2×10^7 cells/mL for specific specific <$10/kg target); MOSA MEAT: 50+; specific serum-free growth factor (specific specific recombinant FGF2 fibroblast growth factor 2: specific specific E. coli expressed recombinant human FGF2 at specific specific $1-5/mg equivalent for specific specific myosatellite cell proliferation media supplement replacing specific specific fetal bovine serum FBS at specific specific <10 ng/mL effective concentration for specific specific >20 population doubling in specific specific serum-free media for specific specific animal welfare + specific specific cost reduction from specific specific FBS $400/L to specific specific recombinant FGF2 equivalent); TUFTS CENTER FOR CELLULAR AGRICULTURE / NEW HARVEST; HARVARD WYSS INSTITUTE: 50+; specific scaffold systems (specific specific decellularized plant scaffold: specific specific spinach leaf or specific specific celery stalk decellularization sodium lauryl sulfate SDS detergent wash for specific specific cellulose ECM scaffold retention with specific specific vascular channel perfusion for specific specific endothelial+muscle cell seeding for specific specific vascularized thick meat analog); BLUENALU: 50+; specific cultivated seafood (specific specific fish cell line immortalization: specific specific teleost muscle+fat cell from specific specific Pacific Bluefin Tuna or specific specific mahi-mahi for specific specific stable proliferating cell line without specific specific myosatellite cell primary culture limitations).

Cell culture scaffold design that enables thick muscle tissue formation; serum-free media with defined recombinant growth factors replacing fetal bovine serum; and bioreactor configurations scaled for food-grade cell culture represent the three primary innovation axes in cellular agriculture where startups are building defensible IP: SCAFFOLD PATENT INNOVATIONS: MATRIX FT; TIAMAT SCIENCES; ATLAST FOOD CO; NEW WAVE FOODS; FORK+GOOD: specific cell culture scaffold (specific specific decellularized plant ECM scaffold: specific specific decellularization SDS+Triton X-100+DNase/RNase wash protocol for specific specific plant tissue for specific specific cellulose-based 3D scaffold with specific specific preserved vascular channel architecture for specific specific muscle cell seeding+growth for specific specific cm-scale vascularized thick meat analog >3mm; specific specific edible scaffold: specific specific food-grade natural polymer scaffold from specific specific soy protein concentrate or specific specific pea protein or specific specific methylcellulose or specific specific agar+gelatin blend for specific specific myoblast+myocyte seeding for specific specific structural support for specific specific aligned muscle fiber formation without specific specific non-food-grade material; specific specific fibrous scaffold: specific specific electrospun PLGA or specific specific silk fibroin or specific specific PCL fiber scaffold from specific specific 0.1-10μm diameter fiber for specific specific contact guidance for specific specific muscle cell alignment along specific specific fiber axis for specific specific striated muscle texture; specific specific alginate microencapsulation: specific specific sodium alginate 1-2% + specific specific CaCl2 crosslinking for specific specific cell+growth factor co-encapsulation bead for specific specific protection during bioreactor turbulence); SERUM-FREE MEDIA PATENTS: MOSA MEAT; JUST INC; CELLULAR AGRICULTURE SOCIETY; TUFTS; UNIVERSITY OF BATH: specific serum-free media (specific specific recombinant FGF2: Mosa Meat specific specific E. coli expressed rFGF2 $1-5/mg; specific specific recombinant IGF-1 insulin-like growth factor 1 for specific specific satellite cell proliferation+differentiation signaling pathway activation for specific specific serum-free condition; specific specific recombinant HGF hepatocyte growth factor for specific specific satellite cell activation from specific specific quiescence for specific specific high-efficiency isolation; specific specific small molecule myosatellite activator: specific specific SB431542 TGF-β inhibitor + specific specific CHIR99021 GSK3β inhibitor for specific specific Wnt pathway for specific specific satellite cell self-renewal without specific specific growth factor for specific specific cost reduction to specific specific <$1/L); BIOREACTOR PATENTS: GOOD MEAT; AVANT MEATS; MEATABLE; ESCO ASTER; SARTORIUS; CYTOVANCE: specific cell culture bioreactor (specific specific microcarrier stirred tank bioreactor STR: specific specific Rushton impeller 0.5-1 W/L specific specific specific power-to-volume ratio at specific specific 50-300 rpm for specific specific dextran microcarrier at specific specific 5 g/L for specific specific adherent cell suspension at specific specific <0.1 Pa shear stress for specific specific specific cell viability >90%; specific specific hollow fiber perfusion bioreactor: specific specific 0.2μm hollow fiber membrane for specific specific continuous media perfusion at specific specific 1-3 reactor volume/day for specific specific high-density >10^8 cells/mL culture for specific specific reduced growth factor media cost vs. specific specific batch).

Muscle cell differentiation from satellite cells into myotubes; fat cell adipogenesis and co-culture with muscle for flavor; and post-processing methods for converting cell biomass into structured meat-like texture represent three additional technically differentiated areas of active cellular agriculture patent development: MUSCLE DIFFERENTIATION PATENTS: UPSIDE FOODS; MEATABLE; FORK+GOOD; TUFTS; ACADEMIA SINICA: specific muscle differentiation (specific specific differentiation induction protocol: specific specific serum-free differentiation medium from specific specific horse serum substitute → specific specific defined differentiation medium for specific specific myogenic regulatory factor Myf5+MyoD+myogenin transcription factor expression for specific specific satellite cell fusion into specific specific multinucleated myotube at specific specific >85% fusion index for specific specific striated muscle cell phenotype; specific specific electrical stimulation: specific specific monophasic 2ms pulse 10V/cm 1Hz from specific specific carbon electrode bioreactor for specific specific myotube contraction for specific specific sarcomere organization + specific specific myosin heavy chain MHC expression for specific specific mature myofiber formation for specific specific improved texture vs. specific specific unstimulated culture; specific specific stretch bioreactor: specific specific cyclic uniaxial strain 10% elongation 0.1Hz from specific specific motorized PDMS culture substrate for specific specific aligned myotube bundle formation for specific specific anisotropic texture mimicking specific specific muscle grain); FAT CELL PATENTS: GOOD MEAT; MOSA MEAT; NEW SCHOOL FOODS; UMAMI MEATS: specific fat cell co-culture (specific specific adipogenic differentiation: specific specific preadipocyte from specific specific stromal vascular fraction SVF isolation from specific specific adipose biopsy for specific specific PPAR-γ+C/EBPα adipogenic transcription factor induction in specific specific differentiation medium from specific specific insulin+dexamethasone+IBMX for specific specific lipid droplet accumulation oleic+palmitic fatty acid composition in specific specific intramuscular fat IMF for specific specific flavor + specific specific mouthfeel marbling analog; specific specific co-culture ratio: specific specific muscle+fat 9:1 to specific specific 8:2 cell ratio co-culture for specific specific flavor compound release on specific specific cooking for specific specific Maillard reaction precursor from specific specific lipid+amino acid for specific specific meat-like aroma); POST-PROCESSING PATENTS: MATRIX FT; NEW WAVE FOODS; BALLETIC FOODS; AVANT MEATS: specific cultivated meat post-processing (specific specific thermally induced gelation: specific specific myosin+actin protein network formation at specific specific 60-72°C gel point for specific specific cultivated muscle biomass for specific specific structural cohesion of specific specific unstructured cell mass into specific specific sliceable meat-analog; specific specific high-moisture extrusion: specific specific twin-screw extruder for specific specific cultivated cell mass+plant protein blend for specific specific fibrous texture for specific specific ground cultivated meat structured patty analog with specific specific improved texture vs. specific specific unprocessed cell mass).

Cellular agriculture startup IP strategy must navigate a nascent but rapidly developing patent landscape with less prior art than traditional food biotechnology — creating genuine whitespace opportunities but also uncertainty about claim scope and enforcement: CELLULAR AGRICULTURE STARTUP IP STRATEGY: UNDERSTAND THE CELLULAR AGRICULTURE IP LANDSCAPE: YOUNGER AND LESS CONCENTRATED THAN PRECISION FERMENTATION: cellular agriculture patent density is lower than food ingredient fermentation or plant-based protein — fewer than 2,000 total granted patents globally vs. tens of thousands in industrial fermentation; first-to-file advantage is significant in this domain; UPSIDE FOODS + GOOD MEAT = LARGEST CULTIVATED MEAT PORTFOLIOS: Upside Foods (100+) and Good Meat/Eat Just (100+) have built the two largest cultivated meat IP portfolios but both portfolios remain modest by traditional biotech standards; key patents cover cell isolation+expansion, specific growth media formulations, bioreactor configurations; ACADEMIC INSTITUTIONS HOLD FOUNDATIONAL SCAFFOLD IP: Tufts Center, Harvard Wyss, and New Harvest funded significant early R&D — foundational scaffold and differentiation protocol IP may be held in academic licenses; check licensing availability for university scaffold IP before building product on academic methods; MOSA MEAT&apos;S FGF2 CONTRIBUTIONS: Mosa Meat published extensively on serum-free FGF2 — creating prior art that may limit broad claims on rFGF2 serum replacement but also preventing others from claiming it broadly; WHEN TO PATENT IN CELLULAR AGRICULTURE: NOVEL CELL LINE WITH MEASURED PERFORMANCE: specific novel primary cell isolation method or specific specific cell line immortalization approach with specific measured population doubling time hours + specific specific doubling number before senescence + specific specific myogenic marker expression % + specific specific serum-free condition compatibility vs. specific specific standard satellite cell isolation or specific specific FBS-dependent culture; NOVEL SCAFFOLD MATERIAL + FUNCTIONAL OUTCOME: specific novel food-grade scaffold material (specific specific protein polymer + specific specific crosslinking chemistry) with specific measured cell alignment % + specific specific muscle bundle tensile strength kPa + specific specific fiber diameter μm + specific specific degradation profile in specific specific eating simulation vs. specific specific prior art scaffold; NOVEL GROWTH MEDIA FORMULATION: specific novel defined serum-free media with specific measured proliferation rate doublings/day + specific specific cost $/L at specific specific recombinant growth factor concentration + specific specific cell viability % over specific specific 20+ population doublings vs. specific specific FBS-containing media — cost data critical for commercial relevance; NOVEL BIOREACTOR CONFIGURATION: specific novel bioreactor shear control mechanism or specific specific microcarrier surface chemistry with specific measured cell viability % at specific specific scale + specific specific volumetric cell productivity cells/L/day vs. specific specific standard stirred tank; REGULATORY MOAT: FDA+USDA joint pre-market consultation completed by Upside Foods and Good Meat 2023 — remaining cellular agriculture startups must complete their own regulatory engagement; this is non-IP but creates real barrier; § 101: cell isolation and culture methods are clearly patent-eligible; media formulation = patentable; scaffold material structure+function = patentable; animal cell line isolation alone may face § 101 challenges if claim is directed to naturally-occurring cell; TRADE SECRETS: serum-free media exact component ratios + supplier sources; cell banking cryopreservation protocol; bioreactor scale-up parameter profile; supplier relationships for recombinant growth factors; KEY FTO: Upside Foods myosatellite cell isolation biopsy+CD56 bead selection + scaffold-free fibrin/GelMA thick tissue; Good Meat 250,000L microcarrier suspension + serum-free suspension; Mosa Meat rFGF2 E. coli expression serum-free proliferation; Tufts decellularized plant SDS/Triton ECM scaffold vascular channel; Meatable iPSC-derived satellite cell platform; Harvard Wyss fibrin hydrogel scaffold; electrospun fiber contact guidance scaffold.